Detailansicht

Wissensnetz

Person

Benjamin Egenlauf (1978-)

Arzt

Name	Benjamin Egenlauf
Zeit	1978- (Lebensdaten)
Ort	Heidelberg (Geburtsort) Heidelberg (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Benjamin Peter Egenlauf
Beziehung	Klinikum Heidelberg
Weitere Angaben	Diss. Medizinische Fakultät an der Universität Heidelberg; Oberarzt der Abteilung Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	14348091X
Datensatz-ID	14348091X
Beteiligt an alle anzeigen Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension Diagnose Algorithmus der pulmonalen Hypertonie und Screening-Verfahren Die neue Definition und Klassifikation der pulmonalen Hypertonie Beeinträchtigung der inspiratorischen Muskelfunktion nach COVID-19 Gezielte medikamentöse Therapie der pulmonalarteriellen Hypertonie nach den aktuellen Leitlinien Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients? Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease Impairment of Inspiratory Muscle Function after COVID-19 Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension Disseminated Mycosis by Arthrocladium fulminans Jeopardizing a Patient with GATA2 Deficiency Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study) Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension Ermittlung eines generalisierten Atherosklerosescores durch die MR-Ganzkörperangiographie und dessen Wertigkeit als Prädiktor für das Vorliegen einer koronaren Herzerkrankung

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Benjamin Egenlauf (1978-)

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension

Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension

Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study

Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension

Diagnose Algorithmus der pulmonalen Hypertonie und Screening-Verfahren

Die neue Definition und Klassifikation der pulmonalen Hypertonie

Beeinträchtigung der inspiratorischen Muskelfunktion nach COVID-19

Gezielte medikamentöse Therapie der pulmonalarteriellen Hypertonie nach den aktuellen Leitlinien

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis

The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review

Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension

Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease

Impairment of Inspiratory Muscle Function after COVID-19

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension

Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up

Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study

Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension

Disseminated Mycosis by Arthrocladium fulminans Jeopardizing a Patient with GATA2 Deficiency

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study

Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension

Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension

Ermittlung eines generalisierten Atherosklerosescores durch die MR-Ganzkörperangiographie und dessen Wertigkeit als Prädiktor für das Vorliegen einer koronaren Herzerkrankung